Clinical trial

A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

NCT06177678

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention TFC-003 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention COSOPT ophthalmic solution Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-02-01

PhasePHASE2

Conditions

Primary Open Angle Glaucomaunresolved

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

TFC-003DRUG

COSOPT ophthalmic solutionDRUG

Sponsors & collaborators

Kukje Pharmalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06177678 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.